Effect of Calcium- D Supplement on Hypertension

• Status: Completed
• Trial end date: 2020-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

Triple-blind randomized clinical trial was done on 98 hypertensive women of postmenopausal ages in 2019. The study was executed for 8 weeks with close follow up and , 24-hour Ambulatory blood pressure monitoring (ABPM) was used to record the initial and final blood pressures of all participants. Patients were randomized to calcium-D supplement and placebo

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shiraz University of Medical Sciences
• Treatments: Calcium

Criteria

Inclusion Criteria:

• postmenopausal female with hypertension

• receiving antihypertensive drugs

Exclusion Criteria:

• history of coronary artery disease

• congestive heart failure

• chronic renal disease

• hypercalcemia

• nephrolithiasis

• any other contraindications of calcium use